A 1-SD increase in serum uric acid (91.4 μmol/L) was associated with a 32% elevated risk of persistent atrial fibrillation (adjusted OR: 1.32).
Are higher serum uric acid levels associated with increased atrial fibrillation burden in patients with AF?
Elevated serum uric acid levels are positively associated with a higher atrial fibrillation burden and an increased risk of persistent AF in a dose-dependent manner.
Absolute Event Rate: 0% vs 0%
Objective: This study investigated the association between serum uric acid (UA) levels and atrial fibrillation (AF) burden in Chinese patients with AF. Methods: In this cross-sectional study, AF burden was defined as the proportion of AF duration to total monitoring time, recorded by a patch device over ≥24 hours. Serum UA levels were measured at the start of monitoring. Multivariate logistic regression was used to assess associations. Results: A total of 952 patients with AF (66.4% women; median age 64 years) were included. A 1-SD increase in UA (91.4 μmol/L) was associated with elevated risk of persistent AF (adjusted OR: 1.32; 95% CI: 1.12–1.55; P < 0.001). The highest UA quintile had a greater risk of persistent AF than the lowest quintile of patients (adjusted OR: 2.43; 95% CI: 1.49–3.98; P for trend < 0.001). Conclusion: Serum UA levels are positively associated with AF burden in a dose-dependent manner. UA might serve as an accessible biomarker and potential therapeutic target for AF burden assessment.
Kong et al. (Thu,) reported a other. A 1-SD increase in serum uric acid (91.4 μmol/L) was associated with a 32% elevated risk of persistent atrial fibrillation (adjusted OR: 1.32).